Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Share News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 664.00
Bid: 660.00
Ask: 668.00
Change: 6.00 (0.91%)
Spread: 8.00 (1.212%)
Open: 662.00
High: 672.00
Low: 662.00
Prev. Close: 658.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: New SIG Non-Executive Buys First Shares

Tue, 25th Aug 2015 16:11

LONDON (Alliance News) - The following is a summary of director dealings reported in London on Tuesday and late Monday.
----------
SIG said Non-Executive Director Andrea Abt bought 8,500 shares at a price of EUR2.50 each Tuesday. The purchase is her only holding after being appointed in March.

The company said at the time that Abt offered the building products supplier "significant expertise", having been head of supply chain management and chief procurement officer of the Siemens sector for Infrastructure & Cities from 2011 to 2014. She also is a non-executive at industrial maintenance, repair and overhaul products company Brammer.

SIG shares closed up 3.1% at 184.69 pence Tuesday.
----------
Clothing and food retailer Marks & Spencer Group said Chairman Robert Swannell bought 20,000 shares at a price of 501 pence per share Tuesday. Following this transaction, Swannell holds 140,000 shares. The stock closed up 1.5% at 499.97p Tuesday.
----------
Homeserve said Chairman John Gibson bought 10,000 shares at a price of GBP4.06 per share. Gibson now owns 126,070 shares or 0.04% of issued shares. Shares in the boiler repair company closed up 2.2% at 408.50 pence Tuesday.
----------
Kennedy Wilson Europe Real Estate said Mary Ricks, president and chief executive officer of Kennedy Wilson Europe, bought 20,000 shares at a price of GBP11.697 per share Monday. Following this transaction, Ricks holds 100,916 shares. Shares in the property investment company closed up 0.8% at 1,170.00 pence.
----------
International Biotechnology Trust said Nick Coleman, a partner of the trust's investment manager, SV Life Sciences Managers, purchased 1,129 shares at a price of 487 pence per share Tuesday. Following this transaction, Coleman's aggregate holding increased to 2,040 shares, representing 0.005% of the issued share capital. The stock closed up 3.5% at 515.00p Tuesday.
----------
Schroder UK Growth Fund said Chairman Alan Clifton, with his wife, bought 8,000 shares at a price of 151 pence per share. Following this transaction, Clifton holds a beneficial interest in 50,000 shares, which represents 0.031% stake in the trust. The stock closed up 3.4% at 152.75p Tuesday.
----------
JPMorgan American Investment Trust said Non-Executive Director Kevin Carter bought 12,000 shares at a price of GBP2.4754 per share. Following this transaction, Carter holds 24,000 shares, which represents 0.009% stake in the trust. The stock closed up 4.8% at 254.62 pence Tuesday.
----------
Kainos Group late Monday said that a connected person of Andy Malpass, a director at the company, Friday bought 5,000 shares at GBP1.90 each. Following the transaction, Malpass holds 22,590 shares in the company, representing 0.02% of its issued share capital, and his connected person holds 5,000 shares representing 0.004% of the company's issued share capital. Shares in Kainos closed up 3.1% at 200.00p Tuesday.
----------
Aberdeen Asian Income Fund late Monday said Non-Executive Director Duncan Baxter bought 20,000 shares at 146.50 pence each. Following the transaction on Monday, Baxter now holds 50,714 shares, or 0.026% of the company's issued share capital. Shares in Aberdeen Asian Income Fund closed up 5.1% at 155.25p on Tuesday.
----------
Gresham Computing late Monday said Kestrel Partners on Friday bought 155,000 Gresham shares at GBP0.98 each. Gresham said that 77,500 shares were purchased on behalf of Kestrel Opportunities, of which Kestrel Partners is the investment manager, while the remaining 77,500 shares were purchased on behalf of Kestrel's other discretionary clients. On a combined basis, Kestrel indirectly now holds 6.7 million shares in Gresham, representing 10.6% of its issued share capital. Shares in Gresham closed up 0.4% at 99.40 pence on Tuesday.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
20 Apr 2020 16:07

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
26 Feb 2020 16:22

DIRECTOR DEALINGS: International Biotechnology Director Buys Shares

DIRECTOR DEALINGS: International Biotechnology Director Buys Shares

Read more
11 Dec 2019 17:48

International Biotechnology Trust Declares 12.4 Pence Dividend

International Biotechnology Trust Declares 12.4 Pence Dividend

Read more
29 Oct 2019 13:27

International Biotechnology Net Assets Down But Outperforms Benchmark

International Biotechnology Net Assets Down But Outperforms Benchmark

Read more
10 Jul 2019 16:44

International Biotechnology Declares 14 Pence Interim Dividend

(Alliance News) - International Biotechnology Trust PLC said Wednesday it has declared a 14 pence per share second interim dividend for the year to the end of August.The investment company

Read more
25 Apr 2019 15:26

International Biotechnology Trust Sees Mixed Performance In First Half

LONDON (Alliance News) - International Biotechnology Trust PLC said Thursday it saw a mixed performance against its comparative indices in the first half of its financial year, despite a rise in a

Read more
30 Oct 2018 17:36

International Biotechnology Net Asset Value Rises Despite Volatility

LONDON (Alliance News) - International Biotechnology Trust PLC said Tuesday that its annual net asset value per share increased by 8.6% despite market volatility.For the year ended August a

Read more
13 Dec 2016 17:17

Trump Effect Hits Latin American, Gold Funds In November - QuotedData

Read more
4 Nov 2016 08:27

International Biotechnology Shares Drop As Full Year Returns Suffer

Read more
8 Sep 2016 11:18

Crystal Amber Sparkles Among Investment Funds In August - QuotedData

Read more
5 Aug 2016 12:59

Best And Worst Performing London-Listed Funds In July - QuotedData

Read more
9 Jun 2016 14:22

Best And Worst Performing London-Listed Funds In May - QuotedData

Read more
9 Jun 2016 14:20

Biotech And Healthcare Funds Enjoyed Small Rally In May - QuotedData

Read more
18 Apr 2016 10:06

International Biotechnology Says US Election Pressuring Biotech Stocks

Read more
18 Feb 2016 17:47

DIRECTOR DEALINGS: International Biotechnology Non-Exec Ups Stake

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.